Platelets play a central role in hemostasis and thromboembolic disease, in part adherence to each other (aggregation) or vessel walls (adhesion). These reactions are mediated in part by interactions with a class of large disulfide-linked glycoproteins. We have found that thrombin induces specific and saturable binding of one of these glycoproteins, fibronectin (fn) to platelets. Based on our preliminary data, we envision the interaction of fn with the platelet to involve the four steps diagrammed below. Resting Cell greater than FN Binding Site II greater than Fn Binding III greater than Fn Processing IV greater than Functional. We will dissect and define each of these individual steps in the reaction sequence. Reaction I describes the induction of the fn binding site by platelet stimulation. We shall identify stimuli which do and do not support fn binding using both secretory and non secretory stimuli. The effect of selected drugs on fn binding will be investigated as a means of defining biochemical pathways required for binding site induction. Reaction II entails fn binding to the platelet. The effect of environmental conditions such as temperature, pH and divalent ions, will be established, and the domains of fn which are recognized by the platelet will be defined. In addition, multiple approaches will be used to identify the binding site for fn. Particular emphasis will be given to the role of fibrin(ogen) in fn binding based on our preliminary data. Reaction III entails processing of platelet-bound fn, and we shall investigate cross-linking of fn on the platelet surface via transglutaminases or disulfide bonding, internalization of fn, and interactions with cytoskeletal elements. Reaction IV involves the functional consequences of fn binding to the platelet, either as a result of initial binding or subsequent processing. Its effect on platelet aggregation and adhesion, clot retraction and monocyte-platelet interaction represent likely candidate events which will be explored.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL028235-05
Application #
3339659
Study Section
(EH)
Project Start
1982-01-01
Project End
1986-12-31
Budget Start
1986-01-01
Budget End
1986-12-31
Support Year
5
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
San Diego
State
CA
Country
United States
Zip Code
92037
Chen, Y P; O'Toole, T E; Leong, L et al. (1995) Beta 3 integrin-mediated fibrin clot retraction by nucleated cells: differing behavior of alpha IIb beta 3 and alpha v beta 3. Blood 86:2606-15
Ugarova, T P; Zamarron, C; Veklich, Y et al. (1995) Conformational transitions in the cell binding domain of fibronectin. Biochemistry 34:4457-66
Faull, R J; Ginsberg, M H (1995) Dynamic regulation of integrins. Stem Cells 13:38-46
Ylanne, J; Huuskonen, J; O'Toole, T E et al. (1995) Mutation of the cytoplasmic domain of the integrin beta 3 subunit. Differential effects on cell spreading, recruitment to adhesion plaques, endocytosis, and phagocytosis. J Biol Chem 270:9550-7
Faull, R J; Du, X; Ginsberg, M H (1994) Receptors on platelets. Methods Enzymol 245:183-94
Chen, Y P; O'Toole, T E; Ylanne, J et al. (1994) A point mutation in the integrin beta 3 cytoplasmic domain (S752-->P) impairs bidirectional signaling through alpha IIb beta 3 (platelet glycoprotein IIb-IIIa). Blood 84:1857-65
Du, X; Harris, S J; Tetaz, T J et al. (1994) Association of a phospholipase A2 (14-3-3 protein) with the platelet glycoprotein Ib-IX complex. J Biol Chem 269:18287-90
Bowditch, R D; Hariharan, M; Tominna, E F et al. (1994) Identification of a novel integrin binding site in fibronectin. Differential utilization by beta 3 integrins. J Biol Chem 269:10856-63
O'Toole, T E; Katagiri, Y; Faull, R J et al. (1994) Integrin cytoplasmic domains mediate inside-out signal transduction. J Cell Biol 124:1047-59
Faull, R J; Kovach, N L; Harlan, J M et al. (1994) Stimulation of integrin-mediated adhesion of T lymphocytes and monocytes: two mechanisms with divergent biological consequences. J Exp Med 179:1307-16

Showing the most recent 10 out of 72 publications